Arrowstreet Capital
ALXN

Arrowstreet Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,002,319
Closed -$184M 2022
2021
Q2
$184M Buy
1,002,319
+919,719
+1,113% +$169M 0.23% 86
2021
Q1
$12.6M Buy
+82,600
New +$12.6M 0.02% 769
2020
Q3
Sell
-10,508
Closed -$1.18M 2620
2020
Q2
$1.18M Sell
10,508
-301,649
-97% -$33.8M ﹤0.01% 1703
2020
Q1
$28M Buy
312,157
+197,657
+173% +$17.7M 0.08% 226
2019
Q4
$12.4M Buy
+114,500
New +$12.4M 0.03% 540
2019
Q3
Sell
-13,300
Closed -$1.74M 1792
2019
Q2
$1.74M Buy
+13,300
New +$1.74M ﹤0.01% 941
2019
Q1
Sell
-203,200
Closed -$19.8M 1959
2018
Q4
$19.8M Buy
+203,200
New +$19.8M 0.05% 300
2018
Q3
Sell
-701,814
Closed -$87.1M 1328
2018
Q2
$87.1M Buy
701,814
+227,700
+48% +$28.3M 0.21% 110
2018
Q1
$52.8M Buy
474,114
+163,214
+52% +$18.2M 0.12% 182
2017
Q4
$37.2M Buy
310,900
+282,900
+1,010% +$33.8M 0.09% 218
2017
Q3
$3.93M Sell
28,000
-20,700
-43% -$2.9M 0.01% 539
2017
Q2
$5.93M Buy
48,700
+19,000
+64% +$2.31M 0.02% 439
2017
Q1
$3.6M Buy
+29,700
New +$3.6M 0.01% 649
2016
Q3
Sell
-18,300
Closed -$2.14M 1692
2016
Q2
$2.14M Buy
+18,300
New +$2.14M 0.01% 816
2014
Q4
Sell
-207,571
Closed -$34.4M 1372
2014
Q3
$34.4M Buy
207,571
+132,104
+175% +$21.9M 0.18% 134
2014
Q2
$11.8M Buy
75,467
+18,628
+33% +$2.91M 0.06% 274
2014
Q1
$8.65M Buy
+56,839
New +$8.65M 0.05% 320
2013
Q3
Sell
-351,868
Closed -$32.5M 1158
2013
Q2
$32.5M Buy
+351,868
New +$32.5M 0.24% 101